Maternal and Neonatal Tetanus

    Overview

    Claiming thousands of lives every year, maternal and neonatal tetanus (MNT) is a devastating disease caused by toxins released from Clostridium tetani bacteria. With no cure, MNT is responsible for an average 110,000 deaths a year in the African Region. Once contracted, the newborn usually dies within seven days.

    However, MNT is entirely preventable through appropriate immunization of women of child bearing age, and through simple and basic precautionary measures in child delivery.

    Transmission occurs when there is contact between the bacteria and broken skin or dead tissues, such as the wound resulting when an infant's umbilical cord is cut.

    Poor hygienic conditions, lack of access to sterilized childbirth delivery tools, unhygienic practices, and limited access to health services amplify the risk for MNT during childbirth.

    It is estimated that fewer than 5% of neonatal tetanus cases are actually reported, even from well-developed surveillance systems. It is for this reason that the deaths are greater than the numbers indicate. Of the estimated 28 countries with highest numbers of MNT cases, 16 of them are in the African Region - accounting for 90% global neonatal tetanus cases. These are Angola, Burkina Faso, Cameroon, Chad, Cote d'Ivoire, DR Congo, Ethiopia, Ghana, Guinea Bissau, Liberia, Mali, Mauritania, Mozambique, Niger, Nigeria and Senegal.

    As of May 2026, thirty-four (92%) of the 37 MNT high-burden countries in the African region have been validated for elimination, with the exception of Angola, Central African Republic, and Nigeria that are implementing key public health intervention to achieve the goal.

    Challenges
    • Reaching populations in need of Td/TT vaccines: Rural areas, lacking adequate vaccine service delivery are the areas particularly vulnerable to MNT.
    • Local access to clean and safe delivery practices: The application of clean delivery practices, including the use of sterilized tools to sever the umbilical cord during delivery, clean delivery surfaces and clean hands is crucial in preventing MNT.
    • Effective immunization: For effective prevention, pregnant women must be vaccinated with appropriate number of doses of Td/TT vaccine by the time of their delivery.
    • Slow uptake of TTCV booster doses in routine immunization schedule.
    • Insecurity in the countries that are yet to validate elimination is hampering the progress toward validation of the elimination.
    Our strategies/ interventions
    • Assisting countries to develop an MNT plan of action (PoA), outlining their strategies for eliminating MNT.
    • Vaccinating pregnant women with tetanus toxoid vaccine; esp. immunizing pregnant mothers with at least two doses of tetanus toxoid vaccine before delivery.
    • Identifying high risk districts with low Td/TT2 coverage, low DPT3 coverage and an incidence of neonatal tetanus of more than 1 per 1000 live births and respond with appropriate scale-up of routine immunization activities and mass TT immunization of women of child bearing age.
    • Supporting countries to conduct neonatal tetanus surveillance.
    • Promoting safe child delivery practices.
    • Scale up the implementation of the piloted WHO Immunization & Vaccines Related Implementation Research Advisory Committee (IVIR-AC) endorsed alternative option for assessing MNT elimination in insecure place.

    Featured news